TRILLIUM THERAPEUTICS INC. Increase (Decrease) in Accrued Liabilities
TRILLIUM THERAPEUTICS INC. reported Increase (Decrease) in Accrued Liabilities of $4.96 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2021-11-12
- TRILLIUM THERAPEUTICS INC. increase (decrease) in accrued liabilities for the quarter ending 2021-09-30 was $4.83M.
- TRILLIUM THERAPEUTICS INC. increase (decrease) in accrued liabilities for the quarter ending 2021-06-30 was -$157.00K, a 168.26% decline year-over-year.
- TRILLIUM THERAPEUTICS INC. increase (decrease) in accrued liabilities for the quarter ending 2021-03-31 was $287.00K, a 2107.69% increase year-over-year.
- TRILLIUM THERAPEUTICS INC. increase (decrease) in accrued liabilities for the quarter ending 2020-12-31 was $264.00K.
- TRILLIUM THERAPEUTICS INC. increase (decrease) in accrued liabilities for fiscal 2020 was $322.00K.
- TRILLIUM THERAPEUTICS INC. increase (decrease) in accrued liabilities for fiscal 2019 was -$383.00K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2021-09-30 | $4.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $4.67M derived: sum of 2 quarters · filed 2021-11-12 | $4.96M 10-Q · filed 2021-11-12 | $5.22M derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-06-30 | -$157.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $130.00K 10-Q · filed 2021-08-13 | $394.00K derived: sum of 3 quarters · filed 2021-08-13 | $209.00K derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-03-31 | $287.00K 10-Q · filed 2021-05-07 | $551.00K derived: sum of 2 quarters · filed 2021-05-07 | $366.00K derived: sum of 3 quarters · filed 2021-11-12 | $596.00K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-12-31 | $264.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $79.00K derived: sum of 2 quarters · filed 2021-11-12 | $309.00K derived: sum of 3 quarters · filed 2021-11-12 | $322.00K 10-K · filed 2021-03-18 |
| 2020-09-30 | -$185.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $45.00K derived: sum of 2 quarters · filed 2021-11-12 | $58.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $230.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $243.00K 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | $13.00K 10-Q · filed 2021-05-07 | |||
| 2019-12-31 | -$383.00K 10-K · filed 2021-03-18 |